申请人:AGIOS PHARMACEUTICALS, INC
公开号:US20160280697A1
公开(公告)日:2016-09-29
Compounds and compositions comprising compounds that activate pyruvate kinase M2 (PKM2) are described herein. Also described herein are methods of using the compounds that activate PKM2 in the treatment of cancer.